(iStock image)

VUMC hosts symposium on stem cell transplants and cellular therapies

The Vanderbilt Stem Cell Transplant and Cellular Therapy Symposium offers clinicians detailed information on the latest developments for hematological diseases, ranging from immunotherapies for blood cancers to new, curative therapies for sickle cell disease.

Jeffrey Rathmell, PhD, and Melissa Wolf, PhD. (photo by Susan Urmy)

Study reveals potential new way to stop a common kidney cancer

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.

Jennifer Vega, PhD

Jennifer Vega receives NCCN Foundation Young Investigator Award

Jennifer Vega, PhD, a cognitive neuroscientist and research instructor in the Department of Psychiatry and Behavioral Sciences, has received a 2024 National Comprehensive Cancer Network Foundation Young Investigator Award.

(iStock image)

New urine test has higher diagnostic accuracy for prostate cancer

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the U.S.

Ray Blind, PhD

Ray Blind named associate director for diversity, equity and inclusion at Vanderbilt-Ingram Cancer Center

Ray Blind, PhD, Ingram Assistant Professor of Cancer Research, has been named associate director for Diversity, Equity and Inclusion at Vanderbilt-Ingram Cancer Center

Cathy Eng, MD

Cathy Eng to participate in April 15 congressional briefing

Cathy Eng, MD, will participate in a congressional briefing on April 15 focused on “Addressing Representation in Clinical Trials.”

1 2 3 62